MiMedx Group
Doug Baddley has over 20 years of experience in sales and management roles. Doug has worked at various companies including MiMedx, Shire Regenerative Medicine, Schering-Plough, Pharmacia, Searle, and Excel Marketing.
At MiMedx, Doug served as a Regional Sales Director, where they managed a team and promoted medical and surgical wound care products to various healthcare professionals. Doug also worked as an Account Executive at MiMedx.
Prior to MiMedx, Doug was a Senior Account Manager at Shire Regenerative Medicine, where they focused on sales and marketing of bioengineered human skin substitutes to wound care specialists.
At Schering-Plough, Doug held the position of Specialty District Manager and was responsible for managing a sales team promoting oncology products and hospital-based compounds to medical professionals in different specialties. Doug also served as a District Manager, overseeing a team promoting multiple products to healthcare professionals in 13 states.
Before joining Schering-Plough, Doug worked at Pharmacia as a District Sales Manager, where they supervised and developed a sales team promoting pain/anti-inflammatory, OAB, and hypnotic products to various medical disciplines.
At Searle, Doug worked as a Professional Sales Representative, responsible for sales and marketing of pain/anti-inflammatory and hypnotic products in a specific territory. Doug achieved top rankings and implemented successful action plans to drive sales.
Early in their career, Doug worked as a Manufacturers' Sales Representative at Excel Marketing, where they received awards for sales and training and was recognized for their exceptional performance.
Overall, Doug Baddley has a strong background in sales management, with experience in the healthcare and medical device industries.
Doug Baddley obtained a Bachelor of Arts degree in English/Communication from Weber State University, graduating in 1993.
This person is not in any offices
MiMedx Group
5 followers
MiMedx is a leading biopharmaceutical company developing regenerative medicine and therapeutic biologics utilizing human placental tissue allografts.